These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31695056)

  • 1. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
    Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
    Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.
    Hagiwara S; Murakumo Y; Sato T; Shigetomi T; Mitsudo K; Tohnai I; Ueda M; Takahashi M
    Cancer Sci; 2008 Oct; 99(10):1916-23. PubMed ID: 19016750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD109 in oral squamous cell carcinoma and its clinical significance.
    Chen H; Junji Xu ; Ge R; Liu C
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):145-149. PubMed ID: 38814222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
    Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
    Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
    Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
    Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
    Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
    Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
    Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
    Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
    Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
    Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.
    Liu XX; Feng AP; He YM; Li Y; Wu Y; Lian X; Hu F; Li JW; Tu YT; Chen SJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):132-136. PubMed ID: 26838754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD109 and squamous cell carcinoma.
    Qi R; Dong F; Liu Q; Murakumo Y; Liu J
    J Transl Med; 2018 Apr; 16(1):88. PubMed ID: 29625613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
    Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
    Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
    Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
    J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma.
    Hong KO; Lee JI; Hong SP; Hong SD
    Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.